menu
search
Skip to main content

Investing at the biopharma frontier

Rebecca Sykes, CFA, Global Industry Analyst
November 2023
2024-11-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1414387544

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

The innovations happening in the biopharma industry today are some of the most exciting I’ve seen in my career

Rebecca Sykes, CFA
Portfolio Manager and Global Industry Analyst
Video Player is loading.
Current Time 0:00
Duration 4:20
Loaded: 0.00%
Stream Type LIVE
Remaining Time 4:20
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected

    Expert

    Related insights

    Showing 2 of 2 Insights Posts
    Archived info
    Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

    Private biotech: Immunology and inflammation’s third wave

    Continue reading
    event December 2024
    5 min
    Article
    2025-12-01
    Archived info
    Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
    Archived info
    Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

    Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

    Continue reading
    event October 2024
    8 min
    Article
    2025-10-31
    Archived info
    Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

    Read next